These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16828042)

  • 21. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
    Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
    J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new disorder of lymphocyte apoptosis: combination of autoimmunity, infectious lymphadenopathy, double negative T cells, and impaired activation-induced cell death.
    Hundt M; Posovszky C; Schmidt RE
    Immunobiology; 2002 Dec; 206(5):514-8. PubMed ID: 12607726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
    Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
    Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
    Oliveira JB; Bidère N; Niemela JE; Zheng L; Sakai K; Nix CP; Danner RL; Barb J; Munson PJ; Puck JM; Dale J; Straus SE; Fleisher TA; Lenardo MJ
    Proc Natl Acad Sci U S A; 2007 May; 104(21):8953-8. PubMed ID: 17517660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spotlight on autoimmune lymphoproliferative syndrome.
    Ferrer E; Moral MA; Bozzo J
    Drug News Perspect; 2007 May; 20(4):260-2. PubMed ID: 17637938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in autoimmune lymphoproliferative syndromes.
    Madkaikar M; Mhatre S; Gupta M; Ghosh K
    Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune lymphoproliferative syndrome presenting with glomerulonephritis.
    Kanegane H; Vilela MM; Wang Y; Futatani T; Matsukura H; Miyawaki T
    Pediatr Nephrol; 2003 May; 18(5):454-6. PubMed ID: 12736807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-death signaling and human disease.
    Rieux-Laucat F; Fischer A; Deist FL
    Curr Opin Immunol; 2003 Jun; 15(3):325-31. PubMed ID: 12787759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis--CT and US features.
    Avila NA; Dwyer AJ; Dale JK; Lopatin UA; Sneller MC; Jaffe ES; Puck JM; Straus SE
    Radiology; 1999 Jul; 212(1):257-63. PubMed ID: 10405750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible monoclonal lymphadenopathy in autoimmune lymphoproliferative syndrome with functional FAS (CD95/APO-1) deficiency.
    Ströbel P; Nanan R; Gattenlöhner S; Müller-Deubert S; Müller-Hermelink HK; Kreth HW; Marx A
    Am J Surg Pathol; 1999 Jul; 23(7):829-37. PubMed ID: 10403307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
    Fisher GH; Rosenberg FJ; Straus SE; Dale JK; Middleton LA; Lin AY; Strober W; Lenardo MJ; Puck JM
    Cell; 1995 Jun; 81(6):935-46. PubMed ID: 7540117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.
    Ramenghi U; Bonissoni S; Migliaretti G; DeFranco S; Bottarel F; Gambaruto C; DiFranco D; Priori R; Conti F; Dianzani I; Valesini G; Merletti F; Dianzani U
    Blood; 2000 May; 95(10):3176-82. PubMed ID: 10807785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.
    Siegel RM; Chan FK; Chun HJ; Lenardo MJ
    Nat Immunol; 2000 Dec; 1(6):469-74. PubMed ID: 11101867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune lymphoproliferative syndrome (ALPS) caused by Fas (CD95) mutation mimicking sarcoidosis.
    Müllauer L; Emhofer J; Wohlfart S; Pichlhöfer B; Stary S; Ebetsberger G; Mannhalter C; Chott A
    Am J Surg Pathol; 2008 Feb; 32(2):329-34. PubMed ID: 18223337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
    Bleesing JJ; Brown MR; Straus SE; Dale JK; Siegel RM; Johnson M; Lenardo MJ; Puck JM; Fleisher TA
    Blood; 2001 Oct; 98(8):2466-73. PubMed ID: 11588044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.
    Lenardo M; Chan KM; Hornung F; McFarland H; Siegel R; Wang J; Zheng L
    Annu Rev Immunol; 1999; 17():221-53. PubMed ID: 10358758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
    Wang J; Zheng L; Lobito A; Chan FK; Dale J; Sneller M; Yao X; Puck JM; Straus SE; Lenardo MJ
    Cell; 1999 Jul; 98(1):47-58. PubMed ID: 10412980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes.
    Bosque A; Aguiló JI; del Rey M; Paz-Artal E; Allende LM; Naval J; Anel A
    J Leukoc Biol; 2008 Aug; 84(2):488-98. PubMed ID: 18483205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.
    Drappa J; Vaishnaw AK; Sullivan KE; Chu JL; Elkon KB
    N Engl J Med; 1996 Nov; 335(22):1643-9. PubMed ID: 8929361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
    Bi LL; Pan G; Atkinson TP; Zheng L; Dale JK; Makris C; Reddy V; McDonald JM; Siegel RM; Puck JM; Lenardo MJ; Straus SE
    BMC Med Genet; 2007 Jul; 8():41. PubMed ID: 17605793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.